a new study has claimed that its COVID-19 vaccine raises the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) - a rare but fatal blood clotting disorder. The study, conducted by researchers at Flinders University in Australia, found the presence of PF4 antibodies, which were previously red-flagged by scientists from Canada, North America, Germany, and Italy in 2023.